Avandamet Bioequivalence Study Brazil - Fed Administration

Clinical trial NCT01332071 · COMPLETED

Trial details

NCT number: NCT01332071
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-11-24
Primary completion: 2009-12-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.